Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Fig. 5

Prognostic assessment of the risk signature in test cohort. A–C The risk score distribution, survival status, expression heatmap of nine immune-related eRNAs between high- and low-risk groups in test set. D Kaplan–Meier survival curve analysis for comparison of OS in high- and low-risk groups. E Time-dependent ROC curve analysis of the risk signature. F PCA plot of high- and low-risk groups

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us